Elias Vamvakas
CIK 1061865 · Chairman · last filed 2020-07-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TLCV price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 100
MISSISSAUGA, A6 L4W 5M8
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TearLab Corp (TEAR) Delisted | Chairman | 52,140 | — | — | $1.73M | 21 | 2016-06-28 |
| TearLab Corp (OCCXD) Delisted | Chairman of the Board | — | — | — | $0 | 1 | 2008-10-20 |
| TearLab Corp (OCCX) Delisted | Chairman of the Board | 76,190 | — | — | $2.00M | 3 | 2008-10-08 |
| TLC VISION CORP (TLCV) Delisted | Director | 3,816,855 | — | — | -$13.83M | 4 | 2007-06-28 |
Recent Filings · Page 2 of 3
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-09-18 | TearLab Corp (TEAR) Delisted | Mixed | +56,000 | -$89.3K | EDGAR |
| 2011-09-26 | TearLab Corp (TEAR) Delisted | Buy (P) | +10,000 | $10.5K | EDGAR |
| 2011-07-05 | TearLab Corp (TEAR) Delisted | Buy (P) | +104,604 | $190.4K | EDGAR |
| 2011-06-17 | TearLab Corp (TEAR) Delisted | Mixed | +286,766 | $378.1K | EDGAR |
| 2011-04-22 | TearLab Corp (TEAR) Delisted | Other (J) | +24,395 | $0 | EDGAR |
| 2011-04-22 | TearLab Corp (TEAR) Delisted | Buy (P) | +474,820 | $439.2K | EDGAR |
| 2011-04-15 | TearLab Corp (TEAR) Delisted | Other (J) | +163,934 | $200.0K | EDGAR |
| 2010-02-03 | TearLab Corp (TEAR) Delisted | Other (J) | +12,400 | $31.0K | EDGAR |
| 2010-01-27 | TearLab Corp (TEAR) Delisted | Other (J) | +77,153 | $0 | EDGAR |
| 2009-10-02 | TearLab Corp (TEAR) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.